17-27758902-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_000625.4(NOS2):c.3333G>A(p.Glu1111Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00029 in 1,604,340 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
NOS2
NM_000625.4 synonymous
NM_000625.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.153
Publications
1 publications found
Genes affected
NOS2 (HGNC:7873): (nitric oxide synthase 2) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
NOS2 Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 17-27758902-C-T is Benign according to our data. Variant chr17-27758902-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 764639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.153 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00152 AC: 231AN: 152248Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
231
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000437 AC: 105AN: 240300 AF XY: 0.000307 show subpopulations
GnomAD2 exomes
AF:
AC:
105
AN:
240300
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000162 AC: 235AN: 1451974Hom.: 0 Cov.: 31 AF XY: 0.000144 AC XY: 104AN XY: 722004 show subpopulations
GnomAD4 exome
AF:
AC:
235
AN:
1451974
Hom.:
Cov.:
31
AF XY:
AC XY:
104
AN XY:
722004
show subpopulations
African (AFR)
AF:
AC:
188
AN:
33202
American (AMR)
AF:
AC:
16
AN:
43714
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25462
East Asian (EAS)
AF:
AC:
0
AN:
39290
South Asian (SAS)
AF:
AC:
0
AN:
84734
European-Finnish (FIN)
AF:
AC:
0
AN:
52662
Middle Eastern (MID)
AF:
AC:
2
AN:
5656
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1107296
Other (OTH)
AF:
AC:
25
AN:
59958
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00152 AC: 231AN: 152366Hom.: 1 Cov.: 33 AF XY: 0.00142 AC XY: 106AN XY: 74512 show subpopulations
GnomAD4 genome
AF:
AC:
231
AN:
152366
Hom.:
Cov.:
33
AF XY:
AC XY:
106
AN XY:
74512
show subpopulations
African (AFR)
AF:
AC:
216
AN:
41592
American (AMR)
AF:
AC:
15
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68036
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
NOS2: BP4, BP7 -
Aug 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.